Gene · 3598
Papers2,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Haematopoietic cell-derived exosomes in cancer development and therapeutics: From basic science to clinical practice. | Clin Transl Med | 2023 | 37830387 | PubTator, text mining | PubMed |
| IL-13 neutralization attenuates carotid artery intimal hyperplasia and increases endothelial cell migration via modulating the JAK-1/STAT-3 signaling pathway. | Cell Adh Migr | 2023 | 37814455 | PubTator, text mining | PubMed |
| Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches. | Mol Cancer | 2023 | 37803407 | PubTator, text mining | PubMed |
| Present Status and Advances in Chimeric Antigen Receptor T Cell Therapy for Glioblastoma. | Front Biosci (Landmark Ed) | 2023 | 37796692 | PubTator, text mining | PubMed |
| Investigational treatment strategies in glioblastoma: progress made and barriers to success. | Expert Opin Investig Drugs | 2023 | 37796104 | PubTator, text mining | PubMed |
| Double-edged sword of JAK/STAT signaling pathway in viral infections: novel insights into virotherapy. | Cell Commun Signal | 2023 | 37784164 | PubTator, text mining | PubMed |
| Bridging the age gap: a review of molecularly informed treatments for glioma in adolescents and young adults. | Front Oncol | 2023 | 37781183 | PubTator, text mining | PubMed |
| Tyrosine kinase signaling-independent MET-targeting with CAR-T cells. | J Transl Med | 2023 | 37779207 | PubTator, text mining | PubMed |
| Pro-tumor Tfh2 cells induce detrimental IgG4 production and PGE2-dependent IgE inhibition in pancreatic cancer. | EBioMedicine | 2023 | 37776595 | PubTator, text mining | PubMed |
| A Shortcut from Genome to Drug: The Employment of Bioinformatic Tools to Find New Targets for Gastric Cancer Treatment. | Pharmaceutics | 2023 | 37765273 | PubTator, text mining | PubMed |
| Association of Phosphorylated Pyruvate Dehydrogenase with Pyruvate Kinase M2 Promotes PKM2 Stability in Response to Insulin. | Int J Mol Sci | 2023 | 37761999 | PubTator, text mining | PubMed |
| Bispecific T-Cell Engagers and Chimeric Antigen Receptor T-Cell Therapies in Glioblastoma: An Update. | Curr Oncol | 2023 | 37754534 | PubTator, text mining | PubMed |
| Gastrodin synergistically increases migration of interleukin-13 receptor α2 chimeric antigen receptor T cell to the brain against glioblastoma multiforme: A preclinical study. | Phytother Res | 2023 | 37748098 | PubTator, text mining | PubMed |
| Immunotherapy: a promising approach for glioma treatment. | Front Immunol | 2023 | 37744349 | PubTator, text mining | PubMed |
| Biologics and oral small-molecule inhibitors for treatment of pediatric atopic dermatitis: Opportunities and challenges. | Pediatr Investig | 2023 | 37736359 | PubTator, text mining | PubMed |
| The diversity and dynamics of tumor-associated macrophages in recurrent glioblastoma. | Front Immunol | 2023 | 37731483 | PubTator, text mining | PubMed |
| Time-course transcriptome analysis of a double challenge bleomycin-induced lung fibrosis rat model uncovers ECM homoeostasis-related translationally relevant genes. | BMJ Open Respir Res | 2023 | 37730279 | PubTator, text mining | PubMed |
| Correction: Characterization of chimeric antigen receptor modified T cells expressing scFv-IL-13Rα2 after radiolabeling with 89Zirconium oxine for PET imaging. | J Transl Med | 2023 | 37726828 | PubTator, text mining | PubMed |
| In vitro vascular differentiation system efficiently produces natural killer cells for cancer immunotherapies. | Oncoimmunology | 2023 | 37720687 | PubTator, text mining | PubMed |
| Insight into the Progress in CAR-T Cell Therapy and Combination with Other Therapies for Glioblastoma. | Int J Gen Med | 2023 | 37720174 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3598/papers?page=14